Citadel Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-82,400
Closed -$1.27M 13235
2025
Q4
$1.27M Sell
82,400
-50,200
-38% -$553K ﹤0.01% 6886
2025
Q3
$1.32M Buy
132,600
+17,700
+15% +$184K ﹤0.01% 6941
2025
Q2
$1.14M Buy
114,900
+21,600
+23% +$228K ﹤0.01% 6791
2025
Q1
$1.21M Buy
93,300
+8,200
+10% +$109K ﹤0.01% 6533
2024
Q4
$1.09M Sell
85,100
-39,100
-31% -$473K ﹤0.01% 6837
2024
Q3
$1.38M Buy
124,200
+31,000
+33% +$342K ﹤0.01% 6214
2024
Q2
$1.05M Buy
93,200
+33,700
+57% +$392K ﹤0.01% 6488
2024
Q1
$738K Sell
59,500
-7,300
-11% -$95.2K ﹤0.01% 7553
2023
Q4
$934K Sell
66,800
-8,700
-12% -$121K ﹤0.01% 6809
2023
Q3
$1.12M Sell
75,500
-23,100
-23% -$325K ﹤0.01% 6336
2023
Q2
$1.27M Buy
98,600
+22,400
+29% +$255K ﹤0.01% 5960
2023
Q1
$748K Buy
76,200
+5,900
+8% +$63K ﹤0.01% 7419
2022
Q4
$748K Sell
70,300
-18,700
-21% -$217K ﹤0.01% 7400
2022
Q3
$929K Sell
89,000
-44,300
-33% -$577K ﹤0.01% 7156
2022
Q2
$1.68M Sell
133,300
-25,300
-16% -$269K ﹤0.01% 5906
2022
Q1
$1.72M Sell
158,600
-35,000
-18% -$425K ﹤0.01% 6421
2021
Q4
$2.72M Sell
193,600
-90,800
-32% -$1.49M ﹤0.01% 5527
2021
Q3
$5.46M Buy
284,400
+40,800
+17% +$542K ﹤0.01% 4141
2021
Q2
$2.4M Sell
243,600
-140,700
-37% -$1.28M ﹤0.01% 6146
2021
Q1
$3.78M Buy
384,300
+258,500
+205% +$2.13M ﹤0.01% 4902
2020
Q4
$560K Sell
125,800
-55,800
-31% -$253K ﹤0.01% 7926
2020
Q3
$785K Buy
181,600
+20,800
+13% +$148K ﹤0.01% 6470
2020
Q2
$1.43M Buy
160,800
+123,600
+332% +$625K ﹤0.01% 5173
2020
Q1
$131K Sell
37,200
-49,200
-57% -$228K ﹤0.01% 8406
2019
Q4
$494K Sell
86,400
-60,000
-41% -$321K ﹤0.01% 6821
2019
Q3
$523K Sell
146,400
-12,800
-8% -$49.6K ﹤0.01% 6663
2019
Q2
$635K Buy
159,200
+81,000
+104% +$470K ﹤0.01% 6442
2019
Q1
$572K Sell
78,200
-29,700
-28% -$290K ﹤0.01% 6572
2018
Q4
$987K Buy
107,900
+49,500
+85% +$548K ﹤0.01% 5327
2018
Q3
$724K Buy
58,400
+4,400
+8% +$59.5K ﹤0.01% 6101
2018
Q2
$824K Sell
54,000
-15,600
-22% -$270K ﹤0.01% 5537
2018
Q1
$1.38M Sell
69,600
-46,800
-40% -$808K ﹤0.01% 4306
2017
Q4
$2.18M Sell
116,400
-55,000
-32% -$1.1M ﹤0.01% 3518
2017
Q3
$3.69M Buy
171,400
+76,400
+80% +$1.21M ﹤0.01% 2660
2017
Q2
$917K Buy
95,000
+56,800
+149% +$369K ﹤0.01% 4208
2017
Q1
$227K Sell
38,200
-29,300
-43% -$141K ﹤0.01% 6321
2016
Q4
$267K Sell
67,500
-32,500
-33% -$238K ﹤0.01% 5841
2016
Q3
$1.05M Buy
100,000
+38,500
+63% +$553K ﹤0.01% 3776
2016
Q2
$897K Buy
61,500
+10,100
+20% +$173K ﹤0.01% 3697
2016
Q1
$989K Buy
51,400
+7,700
+18% +$156K ﹤0.01% 3501
2015
Q4
$1.06M Buy
43,700
+12,200
+39% +$306K ﹤0.01% 3491
2015
Q3
$773K Buy
31,500
+2,700
+9% +$76.5K ﹤0.01% 4163
2015
Q2
$675K Sell
28,800
-8,600
-23% -$187K ﹤0.01% 4526
2015
Q1
$839K Buy
37,400
+6,700
+22% +$128K ﹤0.01% 4166
2014
Q4
$518K Buy
30,700
+30,540
+19,088% +$465K ﹤0.01% 4679
2014
Q3
$2K Sell
160
-210
-57% -$3.03K ﹤0.01% 7997
2014
Q2
$6K Sell
370
-70
-16% -$1.06K ﹤0.01% 7694
2014
Q1
$8K Buy
440
+80
+22% +$1.48K ﹤0.01% 7573
2013
Q4
$7K Buy
360
+60
+20% +$878 ﹤0.01% 6778
2013
Q3
$4K Buy
300
+50
+20% +$629 ﹤0.01% 6601
2013
Q2
$3K Buy
+250
New +$5.27K ﹤0.01% 6385

Other funds holding DVAX

Citadel Advisors's DVAX Position: Q1 2026 in Review

Citadel Advisors sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 116,684 shares — an estimated $1.79M sold.

Citadel Advisors first reported a position in DVAX in Q2 2013 and held it in 50 quarters. The position peaked at $38.5M in Q3 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Citadel Advisors reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 116,684 Dynavax Technologies shares in Q1 2026, an estimated $1.79M.
  • Citadel Advisors first reported a position in Dynavax Technologies in Q2 2013 and held it in 50 quarters.
  • Citadel Advisors's Dynavax Technologies position peaked at $38.5M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.